The emerging role of the lung microbiome and its importance in non-small cell lung cancer diagnosis and treatment

Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice

(2021) Se-Hoon Lee et al.   Nature Microbiology

Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients

(2021) Diwakar Davar et al.   SCIENCE

Microbiota Biomarkers for Lung Cancer

(2021) Qixin Leng et al.   Diagnostics

Intestinal Akkermansia muciniphila predicts overall survival in advanced non-small cell lung cancer patients treated with anti-PD-1 antibodies: Results a phase II study.

(2021) Lisa Derosa et al.   JOURNAL OF CLINICAL ONCOLOGY

The role of the gut microbiome on the efficacy of immune checkpoint inhibitors in Japanese responder patients with advanced non-small cell lung cancer

(2020) Yuki Katayama et al.   Translational Lung Cancer Research

Airway Microbiota as a Modulator of Lung Cancer

(2020) Taichiro Goto   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Lower airway bacterial microbiome may influence recurrence after resection of early-stage non–small cell lung cancer

(2020) Santosh K. Patnaik et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Microbiome profile associated with malignant pleural effusion

(2020) Samira Shojaee et al.   PLoS One

Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients

(2020) Peng Song et al.   Thoracic Cancer

Specific gut microbiome signature predicts the early-stage lung cancer

(2020) Yajuan Zheng et al.   Gut Microbes

Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers

(2020) Jennifer L. McQuade et al.   Current Oncology Reports

The Role of the Microbiome in Cancer and Therapy Efficacy: Focus on Lung Cancer

(2020) ADRIENNE HALLEY et al.   ANTICANCER RESEARCH

Microbiomic Analysis on Low Abundant Respiratory Biomass Samples; Improved Recovery of Microbial DNA From Bronchoalveolar Lavage Fluid

(2020) Montserrat Saladié et al.   Frontiers in Microbiology

Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy

(2020) Maitane Ocáriz-Díez et al.   Frontiers in Oncology

Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

(2020) Erez N. Baruch et al.   SCIENCE

Variation in oral microbiome is associated with future risk of lung cancer among never-smokers

(2020) H Dean Hosgood et al.   THORAX

Microbiome dysbiosis in lung cancer: from composition to therapy

(2020) Ning-Ning Liu et al.   npj Precision Oncology

The microbiome and lung cancer

(2019) Abhiram Maddi et al.   Journal of Thoracic Disease

The microbiome, cancer, and cancer therapy

(2019) Beth A. Helmink et al.   NATURE MEDICINE

Modulating the microbiome to improve therapeutic response in cancer

(2019) Jennifer L McQuade et al.   LANCET ONCOLOGY

Commensal Microbiota Promote Lung Cancer Development via γδ T Cells

(2019) Chengcheng Jin et al.   CELL

The Microbiome in Lung Cancer Tissue and Recurrence-Free Survival

(2019) Brandilyn A. Peters et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The diversity of gut microbiome is associated with favorable responses to anti-PD-1 immunotherapy in Chinese non-small cell lung cancer patients

(2019) Yueping Jin et al.   Journal of Thoracic Oncology

A Preliminary Study of Microbiota Diversity in Saliva and Bronchoalveolar Lavage Fluid from Patients with Primary Bronchogenic Carcinoma

(2019) Ke Wang et al.   MEDICAL SCIENCE MONITOR

Microbiota-Derived Short-Chain Fatty Acids Promote the Memory Potential of Antigen-Activated CD8+ T Cells

(2019) Annabell Bachem et al.   IMMUNITY

Methods in Lung Microbiome Research

(2019) Sharon M Carney et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

The lung microbiome: clinical and therapeutic implications

(2019) Alessio Fabbrizzi et al.   Internal and Emergency Medicine

Diminishing microbiome richness and distinction in the lower respiratory tract of lung cancer patients: A multiple comparative study design with independent validation

(2019) Jing Jin et al.   LUNG CANCER

Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer

(2019) Carmine Carbone et al.   MEDIATORS OF INFLAMMATION

Airway Microbiota Is Associated with Up-Regulation of the PI3K Pathway in Lung Cancer

(2018) Jun-Chieh J Tsay et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Interplay between the lung microbiome and lung cancer

(2018) Qixing Mao et al.   CANCER LETTERS

The Unregulated Probiotic Market

(2018) Claudio de Simone   Clinical Gastroenterology and Hepatology

Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography

(2018) Mélanie Deschasaux et al.   NATURE MEDICINE

Regional variation limits applications of healthy gut microbiome reference ranges and disease models

(2018) Yan He et al.   NATURE MEDICINE

PARP1 Is Up-Regulated in Non-small Cell Lung Cancer Tissues in the Presence of the Cyanobacterial Toxin Microcystin

(2018) Patrick L. Apopa et al.   Frontiers in Microbiology

Can the Sputum Microbiota Be a Biomarker that Predicts Mortality after Acute Exacerbations of COPD?

(2018) Jun-Chieh J Tsay et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Dysbiosis of the Salivary Microbiome Is Associated With Non-smoking Female Lung Cancer and Correlated With Immunocytochemistry Markers

(2018) Junjie Yang et al.   Frontiers in Oncology

The microbiome in respiratory medicine: current challenges and future perspectives

(2017) Rosa Faner et al.   EUROPEAN RESPIRATORY JOURNAL

Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects

(2017) Hai-Xia Liu et al.   INTERNATIONAL JOURNAL OF CANCER

A pilot study using metagenomic sequencing of the sputum microbiome suggests potential bacterial biomarkers for lung cancer

(2017) Simon J. S. Cameron et al.   PLoS One

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

(2017) Bertrand Routy et al.   SCIENCE

Desired Turbulence? Gut-Lung Axis, Immunity, and Lung Cancer

(2017) Rea Bingula et al.   Journal of Oncology

The Microbiome and the Respiratory Tract

(2016) Robert P. Dickson et al.   Annual Review of Physiology

Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions

(2016) Sang Hoon Lee et al.   LUNG CANCER

Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials

(2016) Nadja B. Kristensen et al.   Genome Medicine

Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype

(2016) Leopoldo N. Segal et al.   Nature Microbiology

Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy

(2015) A. Sivan et al.   SCIENCE

Microbiota Modulate Tumoral Immune Surveillance in Lung through a   T17 Immune Cell-Dependent Mechanism

(2014) M. Cheng et al.   CANCER RESEARCH

Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis

(2014) Ruben J. Colman et al.   Journal of Crohns & Colitis

The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

(2014) Colin Hill et al.   Nature Reviews Gastroenterology & Hepatology

The microbiome of the lung

(2012) James M. Beck et al.   Translational Research

Role of the Commensal Microbiota in Normal and Pathogenic Host Immune Responses

(2011) Dan R. Littman et al.   Cell Host & Microbe

The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation

(2009) T. Bansal et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA